...
首页> 外文期刊>Oxidative Medicine and Cellular Longevity >African Vegetables (Clerodendrum volibile Leaf and Irvingia gabonensis Seed Extracts) Effectively Mitigate Trastuzumab-Induced Cardiotoxicity in Wistar Rats
【24h】

African Vegetables (Clerodendrum volibile Leaf and Irvingia gabonensis Seed Extracts) Effectively Mitigate Trastuzumab-Induced Cardiotoxicity in Wistar Rats

机译:非洲蔬菜(Clerodendrum Volibile Leags和Irvingia gabonensis籽粒提取物)有效地减轻了Wistar大鼠的曲妥珠单抗诱导的心脏毒性

获取原文
           

摘要

Trastuzumab (TZM) is a humanized monoclonal antibody that has been approved for the clinical management of HER2-positive metastatic breast and gastric cancers but its use is limited by its cumulative dose and off-target cardiotoxicity. Unfortunately, till date, there is no approved antidote to this off-target toxicity. Therefore, an acute study was designed at investigating the protective potential and mechanism(s) of CVE and IGE in TZM-induced cardiotoxicity utilizing cardiac enzyme and oxidative stress markers and histopathological endpoints. 400?mg/kg/day CVE and IGE dissolved in 5% DMSO in sterile water were investigated in Wistar rats injected with 2.25?mg/kg/day/i.p. route of TZM for 7 days, using serum cTnI and LDH, complete lipid profile, cardiac tissue oxidative stress markers assays, and histopathological examination of TZM-intoxicated heart tissue. Results showed that 400?mg/kg/day CVE and IGE profoundly attenuated increases in the serum cTnI and LDH levels but caused no significant alterations in the serum lipids and weight gain pattern in the treated rats. CVE and IGE profoundly attenuated alterations in the cardiac tissue oxidative stress markers’ activities while improving TZM-associated cardiac histological lesions. These results suggest that CVE and IGE could be mediating its cardioprotection via antioxidant, free radical scavenging, and antithrombotic mechanisms, thus, highlighting the therapeutic potentials of CVE and IGE in the management of TZM-mediated cardiotoxicity.
机译:Trastuzumab(TZM)是一种人源化单克隆抗体,已被批准用于HER2阳性转移性乳腺和胃癌的临床管理,但其使用受其累积剂量和偏离目标心脏毒性的限制。不幸的是,到目前为止,没有批准的解毒剂对这种偏离目标毒性。因此,急性研究在研究CVE和IgE在TZM诱导的心脏毒性中利用心脏酶和氧化应激标记物和组织病理学终点来研究CVE和IgE的保护潜力和机制。 400?Mg / kg /天CVE和IgE在无菌水中溶解在5%DMSO中,在注射2.25μmmg/ kg /天/ i.p的Wistar大鼠中进行了溶解在无菌水中。 TZM的途径7天,采用血清CTNI和LDH,完全脂质型材,心脏组织氧化应激标记物测定,以及TZM醉酒组织的组织病理学检查。结果表明,血清CTNI和LDH水平的400克/千克/天CVE和IgE在血清CTNI和LDH水平中增加了增加,但在处理过的大鼠中血清脂质和体重增加模式没有显着改变。 CVE和IgE在心脏组织氧化应激标记物中的活动中深入衰减,同时改善TZM相关的心脏组织学病变。这些结果表明CVE和IgE可以通过抗氧化剂,自由基清除和抗血栓形成机制介导其心脏保护,因此突出了CVE和IgE在TZM介导的心脏毒性管理中的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号